San Clemente-based cardiac device company AtaCor Medical announced a collaboration with Abbott Laboratories to develop a next ...

Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...

Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

A Fort Worth hospital is participating in an international study to help more people survive cardiac arrest.

The global implantable defibrillator market is projected to grow at a steady CAGR of ~7% during the forecast period, driven by rising cardiovascular disease prevalence, rapid technological innovation, ...

The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...

Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...

Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure still an adequate therapy for prevention of sudden cardiac death?

There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...

Presenter: Stuart J. Connolly, MD, McMaster University (Hamilton, Ontario, CANADA) and Stefan H. Hohnloser, MD, J.W. Goethe University (Frankfurt, Germany) Large randomized clinical trials have ...

BALTIMORE (AP) — Dr. Morton Mower, a former Maryland-based cardiologist who helped invent an automatic implantable defibrillator that has helped countless heart patients live longer and healthier, has ...